Finding ways to diagnose light chain amyloidosis earlier

Early diagnosis of light chain amyloidosis

NIH-funded research Medical College of Wisconsin · NIH-11011349

This study is looking to help doctors spot light chain amyloidosis earlier, especially in Black individuals who might not get diagnosed as quickly, by using smart technology to find patterns in earlier health issues that could signal the disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMedical College of Wisconsin NIH-funded
Lab location1 site (Milwaukee, United States)
Project IDNIH-11011349 on NIH RePORTER

What this research studies

This research focuses on improving the early diagnosis of light chain amyloidosis, a serious blood disorder that can lead to heart failure and other organ dysfunction. The team will analyze patterns of precursor diagnoses that often occur before a patient is diagnosed with AL amyloidosis, particularly in Black individuals who may be underdiagnosed. By using advanced Bayesian machine learning algorithms, the researchers aim to develop an alert system that helps doctors recognize the signs of this disease sooner. This could lead to timely interventions and better patient outcomes.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals who are at risk for light chain amyloidosis, particularly those with precursor conditions like monoclonal gammopathy or those from the Black population.

Not a fit: Patients who have already been diagnosed with advanced light chain amyloidosis may not benefit directly from this research.

Why it matters

Potential benefit: If successful, this research could significantly reduce the time to diagnosis for patients with light chain amyloidosis, potentially improving survival rates and quality of life.

How similar studies have performed: Other research has shown promise in using machine learning approaches for early diagnosis of various conditions, suggesting that this methodology could be effective for light chain amyloidosis as well.

Where this research is happening

Milwaukee, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.